Cardlytics

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cardlytics reports robust Q4 performance and eyes positive cash flow

Cardlytics delivered a strong performance in Q4 2022, marked by robust financial results and operational improvements.
The company's strategic focus on cost management, product enhancements, and consumer engagement bodes well for future growth.
While facing challenges in a competitive landscape, Cardlytics is poised to capitalize on opportunities through innovation and strategic initiatives.
Guidance for Q1 2023 and the target for positive free cash flow in Q3 2023 reflect a positive outlook for the company's financial health.

Cardlytics (CDLX) surpasses Q1 expectations amidst cautious advertiser sentiment

Cardlytics (CDLX) reported strong Q1 2023 earnings, exceeding expectations with growth in unique consumers activating offers and improved cost discipline.
The company faces challenges from cautious advertisers and client concentration risks, requiring strategic management and diversification efforts.
Opportunities for growth include expanding the partner network, driving user engagement, and innovating in product offerings to maintain competitiveness.

Cardlytics reports mixed Q2 results, eyes partnerships for growth

Cardlytics navigated mixed financial results in Q2 2023, focusing on cost optimizations and strategic initiatives. The company aims for positive annual adjusted EBITDA and operating cash flow in 2024 amidst market variability and economic uncertainty.

Cardlytics reports positive Q3 results, eyes global expansion and new products

Cardlytics delivered positive Q3 results, showcasing growth in revenue, partnerships, and strategic initiatives. Challenges include revenue factors and product adoption, while opportunities exist in new product offerings and global expansion. The company remains optimistic about future prospects and business success.

Cardlytics reports record Q4 earnings, eyes growth through redemptions

Cardlytics achieved a milestone with its first positive annual adjusted EBITDA since 2019 and recorded its largest adjusted EBITDA in Q4. The company is strategically positioned for growth with new partnerships, product launches, and a focus on driving redemptions. Challenges lie in maintaining financial performance and capital structure.

Cardlytics (CDLX) posts robust Q1 results, eyes growth opportunities

Cardlytics (CDLX) reported strong Q1 2024 results with notable billings and revenue growth, positive adjusted EBITDA, and progress in strategic initiatives. While facing challenges in Q2 projections and analyst inquiries, the company remains focused on capitalizing on growth opportunities and market trends.

Cardlytics reports mixed Q2 results, focuses on growth opportunities

Cardlytics shows resilience with positive adjusted EBITDA in 2023 and improved financial stability
Despite missing Q2 guidance, the company is addressing delivery issues and focusing on growth areas
Strong relationships with financial institutions and plans for business evolution under new leadership
Q3 outlook includes challenges but also opportunities for expansion and performance acceleration

Cardlytics faces Q3 revenue decline, eyes growth through strategic investments

Cardlytics navigated Q3 challenges with a focus on enhancing key aspects of its business. The company's strategic priorities include supply, demand, network performance, and investments in growth initiatives like Bridg and Rippl.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

In 2018, Cardlytics (NASDAQ: CDLX), a tech company that operates as an advertising platform in banks' digital channels, and JPMorgan Chase Bank (NYSE: JPM) struck a PayTech deal.

CDLX stock in focus as Cardlytics' revenue share to JPMorgan decreases

Here is how Cardlytics (CDLX) and Trane Technologies (TT) have performed compared to their sector so far this year.

Is Cardlytics (CDLX) Stock Outpacing Its Business Services Peers This Year?

The consensus price target hints at a 49.3% upside potential for Cardlytics (CDLX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Does Cardlytics (CDLX) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?

Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Nick Lynton – Chief Legal and Privacy Officer Karim Temsamani – Chief Executive Officer Andy Christiansen – Chief Financial Officer Conference Call Participants Kyle Peterson – Needham Operator Good day and thank you for standing by. Welcome to the Q1 2023 Cardlytics, Inc. Earnings Conference Call.

Cardlytics, Inc. (CDLX) Q1 2023 Earnings Call Transcript

Cardlytics (CDLX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.38 per share a year ago.

Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates

Cardlytics (CDLX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CDLX broke through the 200-day moving average, which suggests a long-term bullish trend.

Cardlytics (CDLX) Recently Broke Out Above the 200-Day Moving Average

ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks' digital channels, announced today a determination of the First Anniversary Payment Amount in relation to the acquisition of Bridg. The First Anniversary Payment Amount had been disputed by the parties, and pursuant to the dispute resolution provision of the merger agreement, an Independent Accountant determined the First Anniversary ARR to be $23.2 million.

Cardlytics Announces Update to Bridg Earnout Payments

ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its first quarter ended March 31, 2023 financial results will be released on Thursday, May 4, 2023, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Cardlytics Announces Timing of Its First Quarter 2023 Financial Results Conference Call and Webcast

Cardlytics (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Cardlytics (CDLX) to Report a Decline in Earnings: What to Look Out for

Cardlytics (CDLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Cardlytics (CDLX) Soars 80.9%: Is Further Upside Left in the Stock?

One of today's biggest gainers in an otherwise down market is Cardlytics (NASDAQ: CDLX ). At the time of this writing, CDLX stock is surging around 70% higher on extreme momentum and high volume.

Why Is Cardlytics (CDLX) Stock Up 70% Today?

The stock of finance-focused digital advertising platform Cardlytics (NASDAQ: CDLX), which had been on the downside for most of the past month, has suddenly experienced a significant uptick upon the company announcing its updated guidance for the first quarter of 2023.

Stock to watch: Cardlytics (CDLX) raises Q1 revenue guidance as buying pressure mounts

Cardlytics Inc. shares CDLX, +32.74% were shooting more than 30% higher early in Tuesday's session after the digital-advertising company boosted its quarterly forecast. Cardlytics now expects $63.5 million to $66.5 million in revenue for the first quarter, whereas its prior outlook was for $54.0 million to $63.0 million.

Cardlytics stock soars more than 30% after company boosts forecast

ATLANTA, April 04, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a digital advertising platform, today announced updated guidance for the first quarter ended March 31, 2023.

Cardlytics Announces Updated Guidance for First Quarter 2023 Financial Results

Cardlytics Inc. CDLX, -15.19% said late Wednesday that its chief financial officer is resigning over the summer. Andy Christiansen told the company on Friday that his last day is July 21, but will remain for a transition period, the company said.

Cardlytics seeks new CFO after current one announces resignation

ATLANTA, March 22, 2023 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks' digital channels, announced today that Andy Christiansen, Chief Financial Officer, informed the Company on March 17, 2023 that he is resigning from his position effective July 21, 2023. Christiansen will remain in his position during the transition period.

Cardlytics Announces CFO Transition

ATLANTA, March 14, 2023 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks' digital channels, announced today that the company borrowed $30.0 million under its available $60.0 million line of credit with Pacific Western Bank.

Cardlytics Announces Partial Drawdown of Line of Credit in Response to Uncertainty in the Financial Sector

CDLX's Q4 numbers are bad, but it was expected. The newly appointed CEO is implementing significant modifications to the company's operations in order to increase efficiency.

Cardlytics Is Moving Towards Positive Free Cash Flow

Cardlytics, Inc. (NASDAQ:CDLX ) Q4 2022 Earnings Conference Call March 1, 2023 5:00 PM ET Company Representatives Karim Temsamani - Chief Executive Officer Andy Christiansen - Chief Financial Officer Nick Lynton - Chief Legal and Privacy Officer Conference Call Participants Kyle Peterson - Needham & Company Douglas Anmuth - JPMorgan Jason Kreyer - Craig-Hallum Operator Hello! And thank you for standing by.

Cardlytics, Inc. (CDLX) Q4 2022 Earnings Call Transcript

Cardlytics (CDLX) delivered earnings and revenue surprises of 45.28% and 2.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Cardlytics (CDLX) Reports Q4 Loss, Misses Revenue Estimates

ATLANTA, March 01, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Supplemental information is available on the Investor Relations section of the Cardlytics' website at http://ir.cardlytics.com/.

Cardlytics Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Cardlytics (CDLX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Strength Seen in Cardlytics (CDLX): Can Its 12.1% Jump Turn into More Strength?

ATLANTA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced the appointment of Amit Gupta as its Chief Operating Officer, reporting directly to Karim Temsamani, Chief Executive Officer.

Cardlytics Appoints Amit Gupta as Chief Operating Officer

ATLANTA, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a digital advertising platform, today announced it will present at the 2022 Raymond James Technology Investors Conference.

Cardlytics to Present at the 2022 Raymond James Technology Investors Conference

After losing some value lately, a hammer chart pattern has been formed for Cardlytics (CDLX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

News for Cardlytics Stock (CDLX)